Bevacizumab’s Role in Recurrent Ovarian Cancer
6 Visualizzazioni
• 07/01/23
0
0
Incorporare
administrator
Iscritti
Expert perspectives on bevacizumab’s role in recurrent ovarian cancer, particularly in light of recent PARP inhibitor strategies.
Website: https://www.onclive.com
Twitter: https://twitter.com/OncLive
Facebook: https://www.facebook.com/OncLive/
LinkedIn: https://www.linkedin.com/company/onclive
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti